Delivery Order SPE2DB22D2006-SPE2DB25FV8NC
Award Date
2/20/25
Potential Completion Date
3/13/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,566.90, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,618.40 Firm Fixed Price delivery order contract is for the supply of VEKLURY 100 MG vials, a critical pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,886.60 Firm Fixed Price delivery order is for the procurement of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order (SPE2DB22D2211|SPE2DB25FRHYA) for the supply of VEKLURY 100 MG VIALS, valued at $2,042.76. The contract has a firm-fixed price and is set to be completed by November 20, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The contract is awarded by the Defense Logistics Agency (DLA), a...
This federal contract award, valued at $8,171.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2024. This is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has a significant Indefinite Delivery...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VEKLURY 100 MG VIALS. The $10,213.80 contract has a completion date of February 29, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of a larger indefinite delivery contract with DLA valued up to $999,999,999.00 through...
This federal contract award is for the pharmaceutical product VEKLURY 100 MG VIALS, awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,809.20 firm fixed-price delivery order was placed by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). This contract does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FACN2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm fixed-price delivery order is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product, with a period of performance through November 27, 2024. This contract award is not designated as a set-aside. The DLA, as the primary contracting agency,...